Schey S - Search Results

1

Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma.

Moore S, Atwal S, Sachchithanantham S, Streetly M, Khan I, Percy L, Narat S, D'Sa S, Rabin N, Johnston R, Schey S, Yong K. Moore S, et al. Among authors: schey s. Eur J Haematol. 2013 May;90(5):420-5. doi: 10.1111/ejh.12070. Epub 2013 Mar 14. Eur J Haematol. 2013. PMID: 23294279

2

Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myeloma.

Giles FJ, McSweeney EN, Richards JD, Tobias JS, Gaminara EJ, Grant IR, Kearney JW, Newland AC, Parker NE, Schey S, et al. Giles FJ, et al. Among authors: schey s. Eur J Cancer. 1992;28A(8-9):1392-5. doi: 10.1016/0959-8049(92)90527-9. Eur J Cancer. 1992. PMID: 1515255 Clinical Trial.

3

The use of intravenous intermediate dose melphalan and dexamethasone as induction treatment in the management of de novo multiple myeloma.

Schey SA, Kazmi M, Ireland R, Lakhani A. Schey SA, et al. Eur J Haematol. 1998 Nov;61(5):306-10. doi: 10.1111/j.1600-0609.1998.tb01093.x. Eur J Haematol. 1998. PMID: 9855245

4

A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.

Jackson G, Taylor P, Smith GM, Marcus R, Smith A, Chu P, Littlewood TJ, Duncombe A, Hutchinson M, Mehta AB, Johnson SA, Carey P, MacKie MJ, Ganly PS, Turner GE, Deane M, Schey S, Brookes J, Tollerfield SM, Wilson MP. Jackson G, et al. Among authors: schey s. Br J Haematol. 2001 Jan;112(1):127-37. doi: 10.1046/j.1365-2141.2001.02551.x. Br J Haematol. 2001. PMID: 11167793 Free article. Clinical Trial.

5

The effects of prior induction therapy with melphalan on subsequent peripheral blood progenitor cell transplantation for myeloma.

Kazmi MA, Ahsan G, Schey SA. Kazmi MA, et al. Among authors: schey sa. Clin Lab Haematol. 2001 Apr;23(2):125-9. doi: 10.1046/j.1365-2257.2001.00383.x. Clin Lab Haematol. 2001. PMID: 11488852

6

Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.

Streetly M, Kazmi M, Radia D, Hoyle C, Schey SA. Streetly M, et al. Among authors: schey sa. Bone Marrow Transplant. 2004 Jun;33(11):1131-5. doi: 10.1038/sj.bmt.1704484. Bone Marrow Transplant. 2004. PMID: 15094743 Clinical Trial.

7

Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma.

Schey SA, Fields P, Bartlett JB, Clarke IA, Ashan G, Knight RD, Streetly M, Dalgleish AG. Schey SA, et al. J Clin Oncol. 2004 Aug 15;22(16):3269-76. doi: 10.1200/JCO.2004.10.052. Epub 2004 Jul 12. J Clin Oncol. 2004. PMID: 15249589 Clinical Trial.

8

A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.

Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D, Møller H; Consultant Haematologists, South Thames Haematology Specialist Committee. Phekoo KJ, et al. Among authors: schey sa. Br J Haematol. 2004 Nov;127(3):299-304. doi: 10.1111/j.1365-2141.2004.05207.x. Br J Haematol. 2004. PMID: 15491289 Free article.

9

Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid (CC-4047) and their relationship with venous thrombosis.

Streetly M, Hunt BJ, Parmar K, Jones R, Zeldis J, Schey S. Streetly M, et al. Among authors: schey s. Eur J Haematol. 2005 Apr;74(4):293-6. doi: 10.1111/j.1600-0609.2004.00393.x. Eur J Haematol. 2005. PMID: 15777340

10

The neutropenia induced by the thalidomide analogue CC-4047 in patients with multiple myeloma is associated with an increased percentage of neutrophils bearing CD64.

McCarthy DA, Macey MG, Streetly M, Schey SA, Brown KA. McCarthy DA, et al. Int Immunopharmacol. 2006 Jul;6(7):1194-203. doi: 10.1016/j.intimp.2006.03.001. Epub 2006 Mar 29. Int Immunopharmacol. 2006. PMID: 16714224 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters